This site is intended for UK healthcare professionals only.

Are you a UK healthcare professional?

We are unfortunately unable to allow patients to attend DPC

If you would like more information on diabetes care, please refer to the NHS website.

Visit the NHS website?

DPC 2022



Diabetic Kidney Disease - Emerging Treatment Options

17 Nov 2022
Heart and Kidney Clinic

People with diabetes are at increased risk of CVD.

People with CKD are at increased risk of CVD.

Many patients with diabetes also have CKD which further increases their CVD risk.

Early identification of CKD in patients with diabetes is important to ensure both progression of CKD and CV risks are addressed. Furthermore, recent outcome trials demonstrating a slowing in progression of CKD in patients with diabetes will expand treatment options available

This session will give an overview of the emerging pharmacological data in this field.

  • Discuss why identification and monitoring for CKD is important for renal and cardio-vascular outcomes in patients with diabetes
  • Describe the emerging evidence for improved renal outcomes in the management of patients with diabetes
  • Consider the place of pharmacological therapy in the diabetic CKD pathway
Alison Warren, Consultant Pharmacist Cardiology - University Hospitals Sussex and Sussex ICS